FI90076B - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-pyridyl- och 5-tienyl-2,4-dialkyl-3h-1,2,4-triazol-3-tion-derivat - Google Patents

Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-pyridyl- och 5-tienyl-2,4-dialkyl-3h-1,2,4-triazol-3-tion-derivat Download PDF

Info

Publication number
FI90076B
FI90076B FI864378A FI864378A FI90076B FI 90076 B FI90076 B FI 90076B FI 864378 A FI864378 A FI 864378A FI 864378 A FI864378 A FI 864378A FI 90076 B FI90076 B FI 90076B
Authority
FI
Finland
Prior art keywords
pyridyl
het
triazole
thienyl
process according
Prior art date
Application number
FI864378A
Other languages
English (en)
Finnish (fi)
Other versions
FI90076C (sv
FI864378A (fi
FI864378A0 (fi
Inventor
Francis P Miller
John M Kane
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI864378A0 publication Critical patent/FI864378A0/fi
Publication of FI864378A publication Critical patent/FI864378A/fi
Publication of FI90076B publication Critical patent/FI90076B/fi
Application granted granted Critical
Publication of FI90076C publication Critical patent/FI90076C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Claims (7)

1. Förfarande för framställning av nya terapeu-tiskt användbara 5-pyrldyl- och 5-tienyl-2,4-dialkyl-3H- 5 l,2,4-trlazol-3-tion-derivat med formeln I och farmaceu-tiskt godtagbara salter därav, N-N-R2 Het -β \ I ^ N'' ^ S
10 I R4 i vilken formel R2 och R4 betcknar oberoende av varandra Ci.g-lägre-alkyl och "Het" är 2-, 3- eller 4-pyridyl eller 2- eller 3-tienyl, kännetecknat därav, att en 15 tiosemikarbazid med formeln O S H I) Het-C-NHNR0-CNHR. II 2 4 20 där R2 och R4 betecknar samma som ovan, cykliseras.
2. Förfarande enligt patentkravet 1, känne- t e c k n a t därav, att cykliseringen utförs genom upp-hettning av mellanproduten (II) i ett lämpligt lösnings-medel 1 närvaro av en bas. 25 3. Förfarande enligt patentkravet 2, känne- t e c k n a t därav, att basen är en vattenhaltig bas.
4. Förfarande enligt patentkravet 3, känne-tecknat därav, att upphettningen utförs vid unge-fär refluxionstemperaturen för reaktionsblandningen. 30 5. Förfarande enligt nägot av patentkraven 1-4, kännetecknat därav, att Het är 4-pyridyl.
6. Förarande enligt nägot av patentkraven 1-4, kännetecknat därav, att R2 och R4 betecknar me-tyl.
12. O ? ” '
7. Förfarande enligt nägot av patentkraven 1-4 för framställning av 5-(4-pyridyl)-2,4-dimetyl-3H-l,2,4-tria-zol-3-tion, kännetecknat därav, att som mel-lanprodukt används 2,4-dimetyl-l-(4-pyridoyl)-tiosemikar-5 bazld.
FI864378A 1985-10-29 1986-10-28 Förfarande för framställning av nya terapeutiskt användbara 5-pyridyl- och 5-tienyl-2,4-dialkyl-3H-1,2,4-triazol-3-tion-derivat FI90076C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79236785A 1985-10-29 1985-10-29
US79236785 1985-10-29

Publications (4)

Publication Number Publication Date
FI864378A0 FI864378A0 (fi) 1986-10-28
FI864378A FI864378A (fi) 1987-04-30
FI90076B true FI90076B (fi) 1993-09-15
FI90076C FI90076C (sv) 1993-12-27

Family

ID=25156665

Family Applications (1)

Application Number Title Priority Date Filing Date
FI864378A FI90076C (sv) 1985-10-29 1986-10-28 Förfarande för framställning av nya terapeutiskt användbara 5-pyridyl- och 5-tienyl-2,4-dialkyl-3H-1,2,4-triazol-3-tion-derivat

Country Status (22)

Country Link
US (1) US4952593A (sv)
EP (1) EP0226755B1 (sv)
JP (1) JPH0733382B2 (sv)
KR (1) KR900000368B1 (sv)
CN (1) CN1017899B (sv)
AR (1) AR243179A1 (sv)
AT (1) ATE66218T1 (sv)
AU (1) AU587293B2 (sv)
CA (1) CA1289962C (sv)
DE (1) DE3680885D1 (sv)
DK (1) DK171234B1 (sv)
ES (1) ES2040200T3 (sv)
FI (1) FI90076C (sv)
GR (1) GR3002484T3 (sv)
HU (1) HU196988B (sv)
IE (1) IE58970B1 (sv)
IL (1) IL80435A (sv)
NO (1) NO864307L (sv)
NZ (1) NZ218085A (sv)
PH (1) PH22363A (sv)
PT (1) PT83637B (sv)
ZA (1) ZA868116B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847276A (en) * 1988-09-06 1989-07-11 Merrell Dow Pharmaceuticals Inc. Treatment of thromobocytosis with 5-(4-chlorophenyl)-2,4-diemthyl-3H-1,2,4-triazole-3-thione
US5120347A (en) * 1990-06-21 1992-06-09 Rohm And Haas Company Aryl triazole herbicides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1066200B (de) * 1954-10-13 1959-10-01 The Upjohn Company, Kalamazoo, Mich. (V. St. A.) Verfahren zur Herstellung von Sulfonamiden heterocyclischer Verbindungen
US3037916A (en) * 1956-02-24 1962-06-05 American Cyanamid Co Fermentation of tetracycline
NL281755A (sv) * 1961-08-09
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ATE66218T1 (de) 1991-08-15
DK514786D0 (da) 1986-10-28
PH22363A (en) 1988-08-12
EP0226755A1 (en) 1987-07-01
PT83637B (pt) 1989-01-17
NZ218085A (en) 1989-08-29
DE3680885D1 (de) 1991-09-19
JPH0733382B2 (ja) 1995-04-12
IE58970B1 (en) 1993-12-01
IE862833L (en) 1987-04-29
AU6440886A (en) 1987-04-30
ZA868116B (en) 1987-06-24
AU587293B2 (en) 1989-08-10
DK171234B1 (da) 1996-08-05
CA1289962C (en) 1991-10-01
JPS62106092A (ja) 1987-05-16
PT83637A (en) 1986-11-01
HU196988B (en) 1989-02-28
GR3002484T3 (en) 1992-12-30
KR870004018A (ko) 1987-05-06
IL80435A (en) 1991-06-10
CN1017899B (zh) 1992-08-19
AR243179A1 (es) 1993-07-30
FI90076C (sv) 1993-12-27
NO864307L (no) 1987-04-30
CN86107126A (zh) 1987-06-10
KR900000368B1 (ko) 1990-01-25
FI864378A (fi) 1987-04-30
HUT42469A (en) 1987-07-28
US4952593A (en) 1990-08-28
ES2040200T3 (es) 1993-10-16
FI864378A0 (fi) 1986-10-28
NO864307D0 (no) 1986-10-28
DK514786A (da) 1987-04-30
EP0226755B1 (en) 1991-08-14

Similar Documents

Publication Publication Date Title
EP0435177B1 (en) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-ones and their use as anticonvulsants
FI90076B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 5-pyridyl- och 5-tienyl-2,4-dialkyl-3h-1,2,4-triazol-3-tion-derivat
US4775688A (en) 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
US4912095A (en) 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones useful as antidepressants
EP0221485B1 (en) 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and their use as antidepressants
DE3881712T2 (de) 3-Aryl-5-alkylthio-4H-1,2,4-triazole.
US5856350A (en) 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants
US4775689A (en) 5-(naphthyl)-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants
JPH04334373A (ja) 脊髄損傷による反射異常亢進の処置用3−アリール−5−アルキルチオ−4h−1,2,4−トリアゾール類
JPH0233032B2 (sv)
JPS63201175A (ja) 5‐アリール‐2,4‐ジアルキル‐3h‐1,2,4‐トリアゾール‐3‐チオン類の製法

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: MERRELL DOW PHARMACEUTICALS INC.